Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

biOasis Technologies Ord Shs V.BTI.H

Alternate Symbol(s):  BIOAF

Bioasis Technologies Inc. is a Canada-based biopharmaceutical company focused on research and development of technologies and products intended for the treatment of patients with nervous system, including central nervous system, diseases and disorders. The Company is engaged in the development of its xB 3 platform, which is a peptide-based technology, for the transport of therapeutic agents, in particular biological products, across the blood-brain barrier (BBB). It is focused on both orphan drug indications, including brain cancers, and rare genetic neurodegenerative diseases and neuroinflammatory conditions. The Company is also focused on its Epidermal Growth Factor (EGF) platform for treating rare and orphan neurodegenerative and neuroinflammatory disorders. EGF is a protein that stimulates cell growth and differentiation, notably for myelin producing cells. Its development programs include xB3-001: Brain Metastases, xB3-002: Glioblastoma and xB3-007: Neurodegenerative Disease.


TSXV:BTI.H - Post by User

Comment by chrispion May 06, 2021 2:41pm
145 Views
Post# 33142324

RE:RE:RE:RE:RE:RE:RE:RE:RE:How Low Can It Go?

RE:RE:RE:RE:RE:RE:RE:RE:RE:How Low Can It Go?
Now shareholders are starting to do the same big lot

Wrong again MBT ... geez, this must be getting embarrassing for you, me constantly fact checking you and always finding your, ahem, untruths ;)

70+% of the selling from .64 about three months ago has come from one brokerage, RBC. Another 10% or so came thru anonymous which I would not be surprised is the same person(s) selling thru RBC. Canaccord had about three hundred thousand shares they wanted to sell in the past two weeks also.

The masses are not departing this stock, quite the contrary in fact. Buying up the 3.5m shares over the past three months has been quite an accomplishment for whoever is purchasing them.

Bottom line, the selling being done is being done by a small (very small) group, their reasons for doing so? I have no idea. Maybe they've lost interest in the company, maybe they want to buy a house, maybe they think they can get better returns in dogecoin ... whatever the reason(s), they can be totally unrelated to the specifics of Bioasis.

I'm not following their lead by selling and neither are the majority of shareholders. Are we happy about the current share price? certainly not. But that small group of sellers is not going to change the fate of Bioasis. I have a friend who bought bitcoin near $20k, then watched it drop to about $7k and he sold bc he had a vacation property to pay for. He’s regretting that decision bc his cottage has not appreciated the 200% that bitcoin did had he kept it. The point is, sometimes people sell (and a lot of) shares for reasons that have nothing to do with the company.

Go back and read JD’s posts on this board and over here and his upcoming articles over here where he discusses how valuable the xB3 technology can be. Deborah and company will prove that to us over the coming months!

<< Previous
Bullboard Posts
Next >>